TrialFrontiers in immunology2022

Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer.

Lin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.